SINGAPORE (Feb 26): Analysts are generally neutral on Raffles Medical Group (RMG) after the group yesterday announced that its FY18 earnings saw a slight 0.4% increase y-o-y to $71.1 million, while revenue grew 2.4% to $489.1 million.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply